Cargando…
Prescribing Trends for the Outpatient Treatment of Adolescents and Young Adults with Type 2 Diabetes Mellitus
BACKGROUND: Little is known about U.S. outpatient prescribing trends for type 2 diabetes (T2DM) in adolescents and young adults. OBJECTIVES: To determine (a) trends in the outpatient prescribing of pharmacological and nonpharmacological therapies and (b) factors influencing prescribing trends for ad...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437484/ https://www.ncbi.nlm.nih.gov/pubmed/23127148 http://dx.doi.org/10.18553/jmcp.2012.18.8.607 |
_version_ | 1785092535021993984 |
---|---|
author | Phan, Hanna Porter, Kyle Sill, Bruce Nahata, Milap C. |
author_facet | Phan, Hanna Porter, Kyle Sill, Bruce Nahata, Milap C. |
author_sort | Phan, Hanna |
collection | PubMed |
description | BACKGROUND: Little is known about U.S. outpatient prescribing trends for type 2 diabetes (T2DM) in adolescents and young adults. OBJECTIVES: To determine (a) trends in the outpatient prescribing of pharmacological and nonpharmacological therapies and (b) factors influencing prescribing trends for adolescents and young adults with T2DM. METHODS: A retrospective, cross-sectional analysis was conducted on office visits of adolescents (12-17 years) and young adults (18-39 years) with T2DM or impaired glucose tolerance (IGT), using the National Ambulatory Medical Care Survey (NAMCS) from 1996-2005. Logistic regression was used to test for prescribing trends over time. RESULTS: There were an estimated 1.6 million (93.7% T2DM; 4.4% T2DM + IGT; 1.9% IGT) and 22.2 million (88.1% T2DM; 11.9% IGT) office visits for adolescents (0.4% of all adolescent visits) and young adults (1.2% of all young adult visits) associated with T2DM based on ICD-9-CM codes, respectively. In young adults, diabetes drug mentions increased significantly from 39% of visits with T2DM to 61% in 2004-2005 (P = 0.04). Oral diabetes medication mentions increased from 20% to 49% (P = 0.001). However, reports of nonpharmacological therapy decreased from 53% in 1996-1997 to 37% in 2004-2005 (P = 0.14). CONCLUSIONS: The prescribing of pharmacological treatment for T2DM increased with emphasis on oral agents, while reports of nonpharmacological therapy for T2DM decreased over the 9-year study period with increased use of oral medications in both adolescents and young adults. Health care providers should consistently consider both treatment approaches when prescribing patient care as recommended by treatment guidelines. |
format | Online Article Text |
id | pubmed-10437484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Academy of Managed Care Pharmacy |
record_format | MEDLINE/PubMed |
spelling | pubmed-104374842023-08-21 Prescribing Trends for the Outpatient Treatment of Adolescents and Young Adults with Type 2 Diabetes Mellitus Phan, Hanna Porter, Kyle Sill, Bruce Nahata, Milap C. J Manag Care Pharm Research BACKGROUND: Little is known about U.S. outpatient prescribing trends for type 2 diabetes (T2DM) in adolescents and young adults. OBJECTIVES: To determine (a) trends in the outpatient prescribing of pharmacological and nonpharmacological therapies and (b) factors influencing prescribing trends for adolescents and young adults with T2DM. METHODS: A retrospective, cross-sectional analysis was conducted on office visits of adolescents (12-17 years) and young adults (18-39 years) with T2DM or impaired glucose tolerance (IGT), using the National Ambulatory Medical Care Survey (NAMCS) from 1996-2005. Logistic regression was used to test for prescribing trends over time. RESULTS: There were an estimated 1.6 million (93.7% T2DM; 4.4% T2DM + IGT; 1.9% IGT) and 22.2 million (88.1% T2DM; 11.9% IGT) office visits for adolescents (0.4% of all adolescent visits) and young adults (1.2% of all young adult visits) associated with T2DM based on ICD-9-CM codes, respectively. In young adults, diabetes drug mentions increased significantly from 39% of visits with T2DM to 61% in 2004-2005 (P = 0.04). Oral diabetes medication mentions increased from 20% to 49% (P = 0.001). However, reports of nonpharmacological therapy decreased from 53% in 1996-1997 to 37% in 2004-2005 (P = 0.14). CONCLUSIONS: The prescribing of pharmacological treatment for T2DM increased with emphasis on oral agents, while reports of nonpharmacological therapy for T2DM decreased over the 9-year study period with increased use of oral medications in both adolescents and young adults. Health care providers should consistently consider both treatment approaches when prescribing patient care as recommended by treatment guidelines. Academy of Managed Care Pharmacy 2012-10 /pmc/articles/PMC10437484/ /pubmed/23127148 http://dx.doi.org/10.18553/jmcp.2012.18.8.607 Text en Copyright © 2012, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Research Phan, Hanna Porter, Kyle Sill, Bruce Nahata, Milap C. Prescribing Trends for the Outpatient Treatment of Adolescents and Young Adults with Type 2 Diabetes Mellitus |
title | Prescribing Trends for the Outpatient Treatment of Adolescents and Young Adults with Type 2 Diabetes Mellitus |
title_full | Prescribing Trends for the Outpatient Treatment of Adolescents and Young Adults with Type 2 Diabetes Mellitus |
title_fullStr | Prescribing Trends for the Outpatient Treatment of Adolescents and Young Adults with Type 2 Diabetes Mellitus |
title_full_unstemmed | Prescribing Trends for the Outpatient Treatment of Adolescents and Young Adults with Type 2 Diabetes Mellitus |
title_short | Prescribing Trends for the Outpatient Treatment of Adolescents and Young Adults with Type 2 Diabetes Mellitus |
title_sort | prescribing trends for the outpatient treatment of adolescents and young adults with type 2 diabetes mellitus |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437484/ https://www.ncbi.nlm.nih.gov/pubmed/23127148 http://dx.doi.org/10.18553/jmcp.2012.18.8.607 |
work_keys_str_mv | AT phanhanna prescribingtrendsfortheoutpatienttreatmentofadolescentsandyoungadultswithtype2diabetesmellitus AT porterkyle prescribingtrendsfortheoutpatienttreatmentofadolescentsandyoungadultswithtype2diabetesmellitus AT sillbruce prescribingtrendsfortheoutpatienttreatmentofadolescentsandyoungadultswithtype2diabetesmellitus AT nahatamilapc prescribingtrendsfortheoutpatienttreatmentofadolescentsandyoungadultswithtype2diabetesmellitus |